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1 Introduction and the aim of study 
The oral delivery is by far the most convenient route for drug delivery. But, peptides 
and proteins are poorly bioavailable when administrated orally, mainly due to their 
low mucosal permeability and lack of stability in the gastrointestinal environment, 
resulting in degradation of the compound prior to absorption. Therefore it is desirable 
to develop oral delivery systems, which can protect proteins from the harsh 
conditions in the gastrointestinal tract (GIT) and thus also improve their absorption. 
Liposomal formulations offer the posibility of protection and absorption 
enhancement of poorly bioavailable drugs. Unfortunately, liposomes themselves are 
often unstable in GIT. In presence of acid, lipase and bile salts. It seems desirable to 
develop more stable liposomal formulations. In this work is vitamin E used to 
stabilise the liposomal membrane. Furthermore other lipo- or amphiphilic substances, 
as cholylsarcosine and stearoylamine, are included into the formulations to enhance 
the drug uptake through the intestine. However, major disadvantages of liposomes 
for the oral drug delivery are their short shelf live and the inconvenience of a liquid 
dosage form. To overcome those problems the liposomal formulations can be freeze-
dried. Thus they can be stored over several months and be enclosed in capsules to 
provide a convenient way of application. 
The aim of this work is to develop freeze – dried liposomal formulations based on 
convencional lipid as egg phosphatidylcholine and other components like vitamin E, 
cholylsarcosine and sterylamine. It is crucial, in this work to find methods and 
formulations that provide stable and easy to redisperse liposomes with a low 
polydispersity. 
The techniques used for this project are: 
 Producing liposomes by the film method 
 Forming liposomes by the film method 
 Photon correlation spectroscopy 
 Freeze-drying  
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2 List of abbreviations 
10% Suc     10% Sucrose 
Chol      Cholesterol 
CS      Cholylsarcosine 
DPPC      Dipalmitoyl phosphatidylcholine 
DSPC      Distearoyl phosphatidylcholine 
EPC      Egg phosphatidylcholine 
GIT      Gastrointestinal tract 
GUV      Giant unilamellar vesicles 
LUV      Large unilamellar vesicles 
MLV      Multilamellar large vesicles 
MVV      Multivesicular vesicles 
OLV      Oligolamellar vesicles 
PBS      Phosphate buffer saline 
PCS      Photon Correlation Spectroscopy 
PEG      Polyethylenglycol 
PI      Polydispersity 
PVP      Plasdone K – 29/32 Povidone 
SA      Stearoylamine 
Suc/NaCl      2% Succrose/0,7% NaCl 
SUV      Small unilamellar vesicles 
TPGS      D–alpha tocopherylpolyethylene glycol 
1000succinat – Vitamin E 
Treh/NaCl     6,8%trehalose/0,3%NaCl 
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3 Theoretical part 
3.1 Liposomes 
The field of liposome research has expanded considerably at the end of the 1960s, 
when liposomes were discovered, and has continued up to the present day. 
Liposomes help solve the problem of application of drugs of protein character into 
the body by other than parenteral routes. It is now possible to prepare a wide range of 
liposomes varying in size, phospholipid composition and with various surface 
characteristics, making it possible to satisfy different requirements on a peroral 
application or targeted administration of medicines. The surfaces of liposomes can be 
modified by the choice of bilayer lipids as well as by the incorporation and covalent 
linkage of glycoproteins and synthetic polymers. In comparison with other drug 
carriers, liposomes have some advantages, like biological degradability and relative 
toxicological and immunological safety.
1
  
Liposomes are spherical soft-matter particles consisting of one or more bilayer 
membranes, and are most commonly composed of phospholipids encapsulating a 
volume of aqueous medium. The aqueous medium is typically the same as that in 
which the liposomes are suspended. Liposomes as analogs of natural membranes are 
generally assembled by spontaneous self-organization from pure lipids or lipid 
mixtures. They are formed by interaction of amphiphilic lipids suspended in aqueous 
phase Fig.1.
2
 Hydrophilic molecule drugs may be encapsulated into the interior space 
vesicles, lipophilic molecule drugs may be incorporated into the lipid bilayer, which 
form in to walls liposomes. 
3
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Fig. 1 Schematic illustration of the fundamental self-assembly process.
2
 a) individual 
phospholipid molecule b) bilayer membrane c) liposom 
 
3.1.1 Classification of Liposomes 
Liposomes may be classified based on various characteristics, according to size, 
lamellarity, lipid composition and applications, to name a few. Tab. 1 summarises 
the common types of liposomes.
1
  
Tab. 1 Classification of Liposomes
1
 
According to size 
Small unilamellar vesicles 
Large unilamellar vesicles 
Large multilamellar liposomes 
According to circulation in vivo 
Classical or convention 
liposomes 
Sterically stabilised liposomes 
According to lamellarity 
Unilamellar 
Multilamellar 
According to surface charge 
Cationic/ DNA vector 
Anionic 
Neutral 
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Based on size and lamellarity 
Liposomes are, from a morphological perspective, most frequently classified by their 
size and number of membrane bilayers Fig.2. Liposomes are readily prepared in the 
laboratory by various methods Fig 3.
2
 Unilamellar vesicles are of special interest in 
research, mostly due to their good characterized membrane properties and easy 
preparation. They are divided into three size types: small, large, giant. These three 
groups are the most for analytical application. 
2
  
The size of small unilamellar vesicles (SUV) is in the range of 0.02 µm – 0.2 µm. 
They have only one lipid bilayer. SUV are prepared by sonication or extrusion and 
they size depend on the lipids used, the preparation temperature and the length of 
sonication. 
4
  
The size of large unilamellar vesicles (LUV) is in the range of 0.2 µm – 1.0 µm. 
They are prepared by calcium-induced fusion, sonication of SUV or by extrusion 
through defined pore size filters. The internal capacity of these liposomes is quite 
high.
2,
 
4
  
The size of giant unilamellar vesicles (GUV) is > 1µm.4  
Oligolamellar vesicles (OLV) - This are the vesicles, whose membranes are made up 
of several layers, where the release of the drug slowed down due to a stronger layer 
of lipids. They arise as a by-product in the preparation of LUV.
3
  
Multilamellar vesicles often show physical properties and behavior that are very 
different from the unilamellar species, and they are commonly used for industrial 
applications such as drug delivery and cosmetic. The size of multilamellar large 
vesicles – (MLV) is very different (0.5 µm – 10.0 µm). They have different 
lamellarity and different internal capacity. MLV with a given size can be prepared by 
a careful extrusion through defined pore – size filters with soft pressure.2 
Multivesicular vesicles (MVV) - In a larger vesicles are encapsulated a few smaller 
vesicles. They arise as a by-product in the preparation of MLV.
3
  
10 
 
Fig. 2 Schematic representation of the classification scheme for liposomes.2  
 
 
Fig. 3 Common preparation techniques for different types of liposomes. 
2
 
 
The size of liposomes plays an important role in the clearance of liposomes—the 
extent of its importance differs for classical and sterically stabilised liposomes. There 
is a strong size dependence in the clearance of classical liposomes following 
intravenous administration, as the liposome diameter increases the rate at which the 
liposomes are removed from blood into the reticuloendothelial system will also 
increase.
5
 The ability to produce liposomes of controlled size distribution was 
initially obtained by sonication and by extrusion.
1
 Sterically stabilised liposomes 
11 
 
with average size around 250.0 nm are filtered out slowly by the Kupffer cells of the 
liver. With liposomes sizing 300.0 nm the filtering by the spleen cells is increased, 
presumably by a passive filtration mechanism. 
2
 
Based on circulation time in vivo 
Conventional liposomes have a very simple structure. Their main subpart is egg 
phosphatidylcholin (EPC), then cholesterol in various amounts and a small 
percentage of acidic phospholipids. Cholesterol is added for the increase of liposome 
stability in the presence of plasma, the negative charge is important for aggregation 
blocking. These liposomes are recognized by phagocytic cell of the 
reticuloendothelial system, they are eliminated from the circulation quite quickly, 
their half – life falls with the growing radius, negative surface charge and fluidity.6 
Sterically stabilised liposomes 
By the addition of specific mixtures to the classical liposomes it is possible to gain 
liposomes with greater stability in biological fluids and lesser reactivity to plasma 
proteins and cell surface receptors. First surveys were made with the use of GM1 
gangliosid, phosphatidyl inositol, dipalmitoyl phosphatidylcholine (DPPC) or 
distearoyl phosphatidylcholine (DSPC).  
From the 1990s, bipolar or bolaamphiphile ether lipids are used for the purpose of 
liposomes stabilization; they have unique qualities and are obtained from the cell 
walls of Archaebacteria. These liposomes are then called archeosomes, which are 
usually more resistant to low pH in the stomach.
7
 
Based on surface charge 
Liposomes may have either a positive or a negative charge that is supplied mainly by 
admixtures to normal lipids, because the charge of these classic liposomes is in 
essence neutral. Liposome can be prepared with a substantial negative or positive 
charge. From a practical point of view, the positively charged liposomes are mainly 
of a big importance. Liposomes with a positive charge are sometimes called 
liposomal DNA delivery vectors, as they can be used for a transport of DNA right in 
cancer cells. The liposomes with the surface charge are removed faster than the 
12 
 
classical ones. The negative charged are trapped mainly by the splenic uptake, which 
is about twice faster than for the positively charged liposomes.
1
  
3.1.2 Composition of liposomes 
Liposomes should be prepared from constituents that are safe for use in humans. A 
general pattern is now developing concerning the phospholipids that are tolerated. 
Phospholipids are essentials components of all cell membranes. 
Phosphatidylcholines and phosphatidylglycerols from natural sources, 
semisynthetically or fully synthetically produced, and cholesterol and PEG-ylated 
phosphatidylethanolamine, are frequently encountered in liposomes designed as drug 
carriers for parenteral administration.  
The most utilized lipids are phospholipids. The neutraly charged phosphatidylcholine 
and negatively charged phosphatidic acid, phosphatidylglycerol, phosphatidylserine, 
and phosphatidylethanolamine, each of which has a different combination of fatty 
acid chains in the hydrophobic region of the molelecule. If it is necessary to reduce 
the permeability of fluid crystalline state bilayers, cholesterol is added to the bilayer 
structure. The phospholipids may be from natural sources, semisynthetic, fully 
synthetic.
4
 
Egg phosphatidylcholine (EPC) 
Egg phospatidylcholine is one of the phospholipids, which are part of lecithin. 
Phospholipids are amphiphatic molecule. In the molecule of EPC the non-polar 
(hydrophobic) part consists of two fatty acids. The polar (hydrophilic) part of the 
molecule is made up of esters of choline and phosphate, which is in position 3 of 
glycerol Fig.4. The EPC is capable to create spontaneously in water at a certain 
concentration and temperature spontaneously create lamella, micelles or liposomes. 
For pharmacy, it is particularly advantageous, because it nearly untoxic, it shows no 
contraindications or interactions with medications, is not mutagenic, it is not to 
overdose. 
8
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Fig. 4 Structure of EPC 
 
Cholesterol (Chol) 
Incorporation of cholesterol in liposome bilayer can bring about big changes in the 
preparation of these membranes. It does not form by itself bilayer membrane 
structure, but can be incorporated into phospholipids membrane in very high 
concentration up to 1:1 or 2:1 molar ratios of cholesterol to phospatidylcholine.  
Being an amphipathic molecule, cholesterol Fig 5. inserts into the membrane with its 
hydroxyl group of cholesterol oriented towards the aqueous surface and aliphatic 
chain aligned parallel to the acyl chains in the center of the bilayers and also it 
increases the separation between choline head groups and eliminates the normal 
electrostatic and hydrogen bonding interaction. Cholesterol increases the fluidity of 
liposomal membrane.
9
 
Fig. 5 Structure of cholesterol 
 
Cholylsarcosine (CS) 
It can be described as N - methylglycine conjugated with cholic acid Fig. 6. It is a 
non-toxic bile salt derivate, and is comparable to conventional bile acids, but which 
have the potential carcinogenic risk. CS can be used to increase the absorption of 
peptide drugs) after oral administration (insulin and calcitonin), because it complexes 
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with calcium cations,and causes therefore an increased leakage of tight junctions, 
leading to increased permeation and absorption of peptides.
10
  
From the small or large intestine only a negligible quantity is absorbed, so that even 
long-term administration does not change lipid composition or billiards in liver 
function. In solution it is able to create micelles.
11
 In liposomes can create lipophilic 
ion - pair complexes with various organic cations, which also increases the 
permeability of cations through biological membranes.
12
 The medicine can be used 
in bile salt replecement therapy of short bowel syndrome.
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Fig. 6 Molecule of Cholylsarcosine 
 
Stearylamine (SA) 
Stearylamine is 1-aminooctadecane Fig. 7. It is a fatty amine and cationic surfactant. 
In preparing liposomes it is used quite often, due to it is, because the causes of their 
positive charge. Cationic liposomes are important as vectors for DNA. Moreover, 
they are not so fast uptake from the circulation as anionic liposomes. SA increases 
the stability in slightly acidic or alkaline environment.
14
 It was demonstrated that SA 
effectively reduces leakage of cationic drugs from liposomes. Therefore, is SA 
suitable for the preparation of liposomal drug formulation.
15
  
Fig. 7 Structure of stearylamine 
 
Vitamin E  
Systematic nomenclature is referred to as d-α-Tocopheryl polyethylene glycol 1000 
succinate TPGS Fig. 8. It is a water-soluble derivative of vitamin E. Structural, it is 
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an amphiphilic substance and contains a polar head, which comprises a polyethylene 
glycol and lipophilic tail consisting of tocopherol succinate. This amphiphilic 
character leads to that TPGS creates micelles. TPGS is surface active, so it can be 
used as emulsifier, solubilizer, absorption enhancer or water - soluble source of 
vitamin E. TPGS is among nonioinic surfactants. Providing greater capacity to 
dissolve poorly soluble drugs and being less toxic to biological membranes. When 
used in the liposomes TPGS improves their stability, because the polyethylene glycol 
reduces agregation of liposomes.
16
 
Fig. 8 Structure of TPGS 
 
 
3.1.3 Pharmaceutical application of liposomes 
Liposomes have application in the pharmaceutical, cosmetic and food industries. In 
the pharmacy are liposomes used as drugs carriers, in the biopharmacy and biophysic 
as membrane models. In the dermatological industry they are used for their ability to 
bring drugs into the deeper layers of the skin.
3
  
Topical application 
The topical application of liposomes has a big potential mainly in dermatology. In 
this area, the main asset of liposomes lies in the fact that they open a possibility to 
transport hydrophilic substances into the deep layers of the skin, which was earlier 
impossible. The liposomes are absorbed to the skin relatively quickly. Furthermore, 
liposomes are trapped selectively by hair follicles. This quality allows transporting 
melanin, proteins, genes or little molecules directly into the hair follicle. This is laso 
16 
 
the opportunity for genetic therapy that may restore the hair growth, the old hair 
pigment or to slow the untimely loss of hair.
17
  
Systemic application 
Liposomes in the systemic application of medications are put into effect in treatment 
of many diseases and an intensive research is in motion in many other areas. The 
main advantage of liposomes is the decrease in the systemic toxicity of drugs that are 
transported directly into the effective place by the liposomes. The liposomes protect 
the drug itself from the aggressive influences of the environment into which it is 
applied; they conceal the medication from the cells of the immune system.  
Here is a wide range of liposomes use that is also permanently increasing. Liposomes 
are used in the treatment of cancer already for many years mainly because of their 
ability to decrease the systemic toxicity of these medications and to increase their 
circulation time and effectiveness in the place of desired action. For example, 
doxorubicin closed into polyethlylen glycol coated liposomes has a better 
pharmacokinetic than doxorubicin itself. This formulation is used as an alternative to 
the standard treatment of Karposis sarcoma.
18
  
Liposomes are used also for the treatment of asthma. The medications closed into the 
liposomes – that are applied in the aerosol form – are more effective during the 
relieving bronchial constriction than the medications applied without the liposomes.  
Liposomes find their use also for the treatment of arthritis. The absorption and 
distribution of  prednisolon applied by injection in liposomes and of the free steroid 
in mice have been compared. Liposomal prednisolon was found to be retained by the 
injected tissue for longer periods of time.
19
  
Great hopes with reference to liposomes are rested on the treatment of diabetes by 
using perorally applied insulin. The insulin in the form of spray dried insulin applied 
in an aerosol form was already launched in the market, but, unfortunately, the results 
in the clinical praxes did not live up to the expectations.
1
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3.2 Methods for preparing of liposomes 
3.2.1 Preparing of liposomes by film method 
 Mechanism of Vesicle Formation 
Liposomes are formed when thin lipid films are hydrated and stacks of liquid 
crystalline bilayers become fluid and swell. The hydrated lipid sheets detach during 
agitation and self – close to form large, multilamellar vesicles (LMV) which prevents 
interaction of water with the hydrocarbon core of the bilayer at the edges. Once these 
particles have formed, reducing the size of the particle requires energy input in the 
form of mechanical energy. 
Properties of lipid formulations can vary depending on the composition (cationic, 
anionic, neutral lipid species). However, the same preparation method can be used 
for all lipid vesicles regardless of composition.
20
 
3.2.2 Preparing of lipid for hydration 
When preparing liposomes with mixed lipid composition, the lipids must first be 
dissolved and mixed in an organic solvent to assure a homogeneous mixture of 
lipids. This procces is carried out using chloroform: methanol mixture. The intent is 
to obtain a clear lipid solution for the complete mixing of lipids.  
Typical lipid solutions are prepared at 10 – 20 mg lipid /ml organic solvent, although 
higher concentrations may be used if the lipid solubility and mixing are acceptable. 
Once the lipids are thoroughly mixed in the organic solvent, the solvent is removed 
to yield a lipid film. Vials and flasks are placed in a water bath. For small volumes of 
organic solvent (<1ml), the solvent may be evaporated using a dry nitrogen stream in 
fume hood. For larger volumes, the organic can be solvent was removed by rotary 
evaporation yielding a thin lipid film on the sides of a round bottom flask.  
The lipid film is thoroughly dried to remove residual organic solvent by placing the 
vial or flask for 1 hour in the exsiccator under vacuum. Dry lipid films can be 
removed from the exsiccator and are ready for hydration.
20
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3.2.3 Hydration of lipid film 
Hydration of the dry lipid film is accomplished simply by adding an aqueous 
medium, magnetic stirrer and glass beads into vials or flask with a dry lipid film. 
Hydration time may differ slightly among lipid species and structure, however, a 
hydration time of 30 minutes with vigorous shaking, mixing or stirring is highly 
recommended. The hydration medium is generally determined by the application of 
the lipid vesicles. Suitable hydration media include distilled water, buffer solution, 
saline and nonelectrolytes such as sugar solution.  
The product of hydration is a large, multilamellar vesicle analogous in structure to an 
onion, with each lipid bilayer separated by a water layer. The spacing between lipid 
layers is dictated by composition with poly-hydrating layers being closer together 
than highly charged layers which separate based on electrostatic repulsion. Once a 
stable, hydrated LMV suspension has been produced, the particles can be down sized 
by the method of extrusion.
20
  
3.2.4 Preparing of liposomes by extrusion 
Liposome extrusion is a widely used process in which liposomes are forced under 
pressure through filters with defined pore sizes to generate a homogenous population 
of smaller vesicles with a mean diameter that reflects that of the filter pore.
21
 This 
technique has grown in popularity and has become the most common method of 
reducing multilamellar liosomes (MLV), to large unilamellar liposomes (LUV) for 
model membrane and drug delivery research.
22
  
Extrusion can be performed with a hand - held syringe fitted with a standard 
sterilization filter holder or purpose - built hand - held units, such as those supplied 
by Avanti Lipid and Avestin. These devices Fig. 9 are suitable only for small volume 
applications (<1ml) one example consist of two Hamilton syringes conned by a filter 
holder, allowing for back and forth passage of the sample.
23
 Using this technique a 
dilute suspension of liposomes (composed of liquid crystalline lipid) can be passed 
through the filters to reduce vesicle size. This method, however, is limited by the 
19 
 
back pressure that can be applied manually. Generally, phospholipid concentrations 
must be less than 30mM in order to comfortably extrude liposomes manually.
22
  
Extrusion can be applied to a wide variety of lipid species and mixtures. The sample 
is extruded in an unpaired number. The final extrusion should fill the alternace 
syringe. This is to reduce the chances of contamination with larger particles or 
foreign material.
20
  
Fig. 9 LiposoFast – Basic extruder24 
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3.3 Method for checking the quality of the product 
3.3.1 Photon Correlation Spectroscopy (PCS) 
The size of liposomes is one of their most essential characteristics, as its knowledge 
helps us to estimate the fate of the liposome in the organism: how long the liposome 
will probably be in circulation until it will be caught by the cells of the RES. The 
knowledge of the liposomes size also offers the possibility to estimate its inner 
volume. The fast measuring of the liposomes size offers a control whether or not a 
fault was committed during their production, which is usually the extrusion through 
defined pore-size filters, or whether the membrane was intact.  
There are two methods how the size of liposomes may be found, PCS and the 
electron microscopy. PCS is used massively.  
Photon Correlation Spectroscopy (sometimes referred as Dynamic Light Scattering 
or Quasi – Elastic Light Scattering) is a technique for measuring the size of particles 
typically in the sub micron region. Therefore, it is useful for the determination of 
liposomes size.  
PCS is a very fast method: the sample measurement itself lasts about 10 minutes. If 
we add the time needful for the preparation of the sample in the case of the electron 
microscopy, we get the time in the order of hours. 
In the case of PCS, liposomes are measured in their natural state while during 
electron microscopy, it is necessary to dehydrate the sample in a complicated way or 
to stain it and then to use a difficult freeze fracture technique. While PCS measures a 
distribution of tens up to thousands of particles, the electron microscopy needs 
hundreds of photos for a comparable analysis.
25
 
3.3.2 Principle of PCS 
PCS measures the Brownian motion of particles and correlates it with their size. The 
Brownian motion is a random movement of particles caused by the collisions with 
the molecules of the solvent they are surrounded by. The big particles move slower, 
while the small ones faster. The dimension of the Brownian motion is measured by 
21 
 
the diffusion of the ray of light that passes through the suspended sample. This 
dimension is expressed as so called translational diffusion coefficient (usually given 
the symbol D). The diameter of the particles is then calculated by the Stokes-Einstein 
equation: 
 
D3
Tk
Hd


          (1) 
Where:  d (H) = hydrodynamic diameter [m] 
  D = translational diffusion coefficient [m
2s-1] 
  k = Boltzmann’s constant [1,3810-23 JK-1] 
  T = absolute temperature [K] 
  η = viscosity of solution [Nsm-2] 
The hydrodynamic diameter that is gained from this method corresponds to the 
diameter of a sphere with the same translational coefficient. During the measuring, it 
is necessary to keep the same temperature, as the viscosity of the liquid is dependent 
right on the temperature. 
The translational diffusion coefficient is not dependent only on the size of the 
particle ―core‖, but also on the surface structure of the particle and on the 
concentration and type of ions in medium.
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3.3.3 Optical Configuration of the PCS Instrument  
A typical PCS system consists of six parts Fig.10. In our case, we worked with a 
Zetasizer 3000
®
. The Zetasizer 3000 was used for size determination in the range 
from 10 nm up to 5µm. Typical particle population for this technique are liposomes, 
nanoparticles, membrane vesicles and proteins. A routine size measurement needs 
time period between 5 and 30 minutes. 
Fig. 10 Optical Configuration of PCS Instrument.
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The laser 1 is the light source used to illuminate the sample enclosed in the 
measurement cell 2. The scattered light is then captured by the detector 3, and rotated 
against the incoming laser beam by 90 or 173 degrees or specific angle (according to 
different instrument types). The intensity of the scattered light must fall into a certain 
22 
 
range in order for the detector to measure it correctly. Should the intensity be too 
high, the detector would be saturated and the results very inaccurate. The laser 
source, and consequently the dispersion of light, is regulated by the attenuator 4. The 
scattering intensity of the signal is then relayed to the correlator 5. The correlator 
compares the scattering intensity at successive time intervals to derive its rate of 
variation. Data from the correlator are passed on to the computer 6 to be analysed by 
special software that calculates on their basis the size of the particles in the sample.
28
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3.4 Freeze-drying 
Freeze drying process dates from the time during World War II. Freeze-drying, also 
known as lyophilization or cryodesiccation, is a dehydration process typically used to 
preserve a perishable material. Freeze-drying works by freezing the material and then 
reducing the surrounding pressure and adding enough heat to allow the frozen water 
in the material to sublime directly from the solid phase to gas Fig. 11.
29
  
Fig. 11 The phase diagram of water it shows that at low temperature, (solid) ice is the 
stable phase. At moderate temperatures and high pressure, (liquid) water is the stable 
phase, and at high temperature and low pressure, (gas) vapor is the stable phase. 
Lines separate these phases. 
 
Freeze-drying is a energy and time intensive process. This process has a three 
phases: freezing, primary drying, and secondary drying. Each phase will be discussed 
in charter freeze drying of liposomes. This process occurs in the freeze – dryer Fig. 
12. 
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Fig. 12 Chart of freeze-dryer: 1 vacuum pump, 2 ice condenser chamber, 3 condenser 
coil, 4 acrylic cover, 5 drying chamber, 6 heatable shelf, 7 vacuum-gauge, 8 drain 
valve, 9 engine driven intermediate valve, 10 stoppering device, 11 pressure control 
valve, 12 aeration valve, 13 rubber valve, 14 thermal insulation 
  
 
 
 
The stability, during freeze drying and storage, and the duration of the cycle are the 
two major considerations for freeze-drying process optimization. Given a freeze-
drying process yelding a stable product, the shorter freeze-drying cycle has the 
adventage of higher throughput for a given dryer. At non-optimum conditions, the 
freeze-drying process may compromise drug stability, take longer, and cost more 
than is necessary.
30
  
For the quality control of the products, there are a various methods: differential 
scanning calorimetry, Karl-Fisher titration, photon correlation spectroscopy 
(measurement of size and polydispersity), and functionality assays. 
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The formulation of a FD a product needs so called lyo – and cryoprotectants. 
Cryoprotectants  protecte the protuct during freezing and reduce crystallization of ice 
near the product. Lyoprotectants  protecte the product in the dry state. 
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3.4.1 Lyoprotectants and other excipients 
Lyoprotectants protect liposomes by preventing fusion of liposomes, preventing the 
rupture of bilayers by ice crystals, and maintaining the integrity of the bilayers in the 
absence of water. To do so, the lyoprotectants must form an amorphous, glassy 
matrix in and around the liposomes. Interaction between lyoprotectant and the 
phospholipid head groups is considered especially important for preventing leakage 
during rehydration of liposomes that have a liquid-crystalline bilayer in the hydrated 
state at ambient temperature.
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More recently, a different mechanism was proposed by which sugars may reduce the 
stress on bilayers caused by drying.
32
  Bilayers dried without lyoprotectant approach 
each other closely and the suction of water by the phospholipid causes a lateral 
comprehensive stress. The mere presence of a glass between adjacent bilayers during 
drying provides spacing between bilayers, and in combination with the attraction of 
water by the sugars the compressive stress on the bilayers is reduced.  
The preffered lyoprotectants are disaccharides such a sucrose, maltose, trehalose, 
lactose, etc. The use of excipicients with a low molecular weight, such as sodium 
chloride, glucose, and amino acids, should be minimised. If such excipients remain 
amorphous in the sugar matrix. They will lower the Tg´,glass transition temperature  
of the freeze concentrate and the Tg, glass transition temperature of the freeze-dried 
cake. these quantities will be discussed in more detail in charter freeze-drying of 
liposomes. A low Tg¨ requires freeze-drying at a low product temperature, which is 
an inefficience process. 
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3.4.2 Application of freeze - drying 
The products of lyophilisation process have a various application in pharmaceutical, 
biotechnology, food and technological industries. Freeze-drying is widely used for 
pharmaceuticals to improve the stability and longterm storage stability of labile 
drugs, especially protein drugs.
30
 The freeze-drying is used to increase the shelf life 
of products, such as vaccines and other injectables. By removing the water from the 
material and sealing the material in a vial, the material can be easily stored, shipped, 
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and later reconstituted to its original form. Freeze-drying is also used to preserve 
food and make it very lightweight. The process has been popularized in the forms of 
freeze-dried ice cream, an example of astronaut food.  
3.4.3 Freeze – drying of liposomes  
Freeze-drying of liposomes can prevent hydrolysis of the phospholipids and physical 
degradation of the vesicles during storage. In addition, it may help stabilize the 
substance that is incorporated in the liposomes. Freeze – drying of a liposome 
formulation results in an elegant dry cake, which can be reconstituted within seconds 
to obtain the original dispersion, that is, if the appropriate excipients are used and if 
suitable freeze-drying conditions are applied.
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Freezing phase 
In the freezing phase, cooling of the sample results in the formation of ice crystals. 
As a result, both the remaining solutes and the liposomes become more concentrated. 
At this stage, the lyoprotectants form an amorphous matrix in and around the 
liposomes that prevents fusion process and protects the liposomes against rupture due 
to the growth of ice crystals. As the temperature of the freeze – concentrate is 
lowered and its water content is reduced as a reset of the progression of ice 
formation, the viscosity of the freeze-concentrate increases, until it forms a glass 
with low molecular mobility. The temperature at which this occurs is called Tg, the 
glass transition temperature of the freeze concentrated solution, or, alternatively, the 
collapse temperature (Tc). The Tg is a key parameter for the primary drying process.  
Generally, the product is cooled to about 5°C below Tg´ before the start of the drying 
phase. The Tg´ depends on the composition of the amorphous freeze-concentrate, 
which in most cases contains a lyoprotectant and minimal amount of buffer 
components. The Tg´ values of lyoprotectants are listed in Tab. 2.  
Tab. 2 Glass transitive and collapse temperatures of lyoprotectants 
Component Tg´/°C Tc/°C Tg/°C 
Sugars Sucrose -32 -31 75 
  Trehalose -29 -28.5 118 
Polymers PVP -20.5 -24 180 
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Liposomes do not contribute to the value of Tg. The presence of small molecules 
such as sodium chloride in the amorphous matrix can strongly decrease the Tg. The 
cooling rate of the freezing phase is also an important factor. Slow cooling is 
preferred (e.g., 0.5°/min). Once freezing occurs, the whole sample freezes nearly 
instantaneously, resulting in similar crystal sizes throughout the product. Such pores 
reduce the resistance of the cake to water vapor during sublimation. Moreover, slow 
cooling has been shown to minimase the leakage of contents from liposomes after 
freeze drying and rehydration, depending on the liposome type.
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Primary drying 
During primary drying the ice crystals are sublimated, resulting in the porous cake 
structure of the freeze - concentrated matrix. As long as the product temperature or 
more precisely, the temperature at the sublimation front (Tfront), is maintained at 
about 4° below Tg, degradation of the liposomes is minimized and ice crystals can be 
removed by sublimation without collapse of the cake structure. However, if Tfront  
rises above Tg, collapse of the cake occurs, which results in a reduced surface area of 
the dried matrix. As a consequence, the final residual water content after drying may 
increase, as well as the time required for reconstitution, and the liposomes may fuse 
and lose part of their contents on rehydration.  
The product temperature at the sublimation front is determined by local pressure, 
according to the ice vapor pressure temperature curve Tab 3. For this reason, the 
pressure in the freeze-drying chamber should be controlled well. The set point of the 
pressure is chosen at a value that corresponds to an ice temperature of about 4°C 
below Tg. The shelf temperature should be higher than the ice temperature in order to 
transfer the heat to the sublimation front that is required for drying.  
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Tab. 3 Ice temperature as function of vapor pressure. 
Ice Temperature 
(°C) 
Pressure (Pa) 
-20 86 
-25 59 
-30 37 
-35 22 
-40 12 
-45 07 
-50 04 
The driving force of the drying process is the difference in temperature and, 
therefore, difference in water vapor pressure, between the condenser of the freeze-
dryer and the sublimation front. The condenser temperatures of freeze-dryers reach -
54°C. A limiting factor in the drying process can be the heat transfer from the shelf 
to the sublimation front, which occurs via conduction by glass and ice, as well as by 
gas molecules. Therefore, more heat is available for sublimation at the ice front at a 
higher chamber pressure.
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Secondary drying 
In the secondary drying phase, the residual water content of the amorphous matrix is 
further decreased. After all the ice has disappeared and the product temperature has 
approached the value of the shelf temperature, the secondary drying phase can be 
initiated. For this reason, temperature probes provide useful information during the 
freeze-dry run. In the secondary drying phase, the pressure is reduced to a minimal 
value and the shelf temperature can be gradually increased to. Reduction of the water 
content of the cake also occurs during primary drying, but lower values (<1%) can be 
achieved by adjusting the conditions. Reduction of the water content increases the 
glass temperature Tg of the cake, and this allows a gradual increase in the shelf 
temperature.  
The shelf temperature is a key parameter for obtaining low residual water content. 
Generally, a freeze dried product is likely to be stable at 20 to 30°C below Tg and, 
therefore, reduction of the residual water content as of utmost importance. It is 
worthwhile to mention that the Tg of the amorphous cake is not the only parameter 
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that affects the stability of the freeze-dried liposomes. The physical processes that 
can occur in a cake of freeze-dried liposomes are rather complex, low water contents 
are generally expected to enhance the stability of the dried product. Vials can be 
closed under vacuum or after releasing the vacuum with nitrogen gas or argon.
33
 An 
overview of physical characterizations is in Tab. 4. 
Tab. 4 Physical properties of freeze-drying  
Freeze drying 
stages 
Physical properties/in process transitions 
Freezing 
Super cooling, ice crysallization 
Annealing 
morphology of ice crystals 
Volume expansion due to crystallization 
Primary drying 
Glass transition temperature Tg'/Eutectic 
temp. 
Collapse temperature 
Mobility in frozen state 
Ice sublimation 
Secondary Drying 
Water desorption 
Desorption rate 
Glass transition temperature 
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4 Experimental part 
4.1 Material and Methods 
4.1.1 Material 
Cuvette – Einmal – Küvetten aus Polystyrol; 4,5 ml; 4 klare Seiten (Carl Roth 
GmbH, Germany)  
Eppendorf pipettes (Eppendorf, Hamburg, Germany) 
Eppendorf tubes 1.5ml, 2ml (Eppendorf, Hamburg, Germany) 
Membrane filter - Rotilabo® - Spritzenfilter, steril, 0,22 µm (Carl Roth GmbH, 
Germany) 
Pipette tips (Brand, Wertheim, Germany) 
Polycarbonate membrane, diam. = 19mm, pore diam. = 200 nm (Avestin Europe 
GmbH, Germany) 
Syringe 1ml, 5ml (Becton Dickinson Labware, USA) 
4.1.2 Instruments 
Analytical balance (Sartorius AG Götingren, Germany) 
Christ – Delta 1-20 KD (M. ChristGefriertrocknungsanlage GmbH, Germany) 
Extrudor – LiposoFast Basic (Avestin Europe GmbH, Germany) 
Software – PCS, ver. 1.61 (Malvern Instruments GmbH, Germany) 
Waterbath (Eppendorf, Hamburg, Germany) 
Zetasizer 3000 HS (MalvernInstruments GmbH, Germany) 
 
4.1.3 Chemicals 
d –alpha tocopherylpolyethylene glycol 1000succinat – Vitamin E TPGS NF 
(Eastman, UK) 
D (+) Trehalose (Sigma Aldrich, Germany) 
D (+) Sucrose - (Acros Organics, USA) 
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Distilled water (IPMB, Germany) 
Egg phosphatidylcholine (EPC) (Lipoid, Germany) 
Hydrochloric acid (HCl) (J. T. Baker, Holland) 
Chloroform (CHCl3) (VWR Prolabo, EC) 
Cholesterol (Chol) (Synopharm GmbH, Germany) 
Cholylsarcosine (CS) (Prodotti Chimici e Alimenteri S.p.A., Italy) 
Methanole – HiPerSolv Chromanorm (CH3OH) (VWR Prolabo, EC) 
Plasdone K – 29/32 Povidone (ISP Technologies, USA) 
Potassium chloride (KCl) (AppliChem, Germany) 
Potassium phosphate monobasic (KH2PO4) (J. T. Baker, Holland) 
Sodium chloride (NaCl) (Wassex House, UK) 
Sodium phosphate dibasic dihydrate (Na2HPO4 · 2 H2O) (J. T. Baker, Holland) 
Stearoylamine (SA) (Sigma Aldrich, Germany) 
 
4.2 Preparing of aqueous medium  
I prepared next aqueous solutions by addition of appropriate amount of substance to 
distilled water: 
 6.8% trehalose/0.3% NaCl (Treh/NaCl) 
 10% Succrose (10% Suc) 
 2% Succrose/0.7% NaCl (Suc/NaCl) 
 20% PVP 
Phosphate buffer saline (PBS) 
I weight 8.0 g sodium chloride, 0.2 g potassium chloride, 1.44 g sodium phosphate 
dibasic dihydrate, 0.2 g potassium phosphate monobasic and added to 100.0 ml 
distilled water. This 100.0 ml I added to 850.0 ml distilled water and adjusted the pH 
to 7.4 with hydrochloric acid. I filled up this solution to 1000.0 ml with distilled 
water and filtrated the buffer through a filter of 0.22 µm pore size. 
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4.3 Preparing of liposomes by film method 
4.3.1 Film Formation 
It is necessary to dissolve lipids for preparing liposomes. I separately dissolved each 
lipid in a organic solvent mixture of chloroform: methanol (9:1) to achieve the 
concentration of 10 µmol/ml. In the 5 ml glass vial, I prepared the mixtures of two or 
three lipids according to the proportion of individual lipids Tab 5. The final 
concentration of the solution mixture of lipids was 10 µmol/ml again, and the volume 
in the vial was 1 ml.  
The glass vials were positioned into the water bath at 50° C. The solvent was 
evaporated with a nitrogen stream or under vacuum. The tip of the nitrogen tube was 
positioned near the liquid level. In the range of 5 to 10 minutes, the solvent was 
vaporized. After evaporation of the solvent a lipid film created on the wall. The lipid 
film I maintained under vacuum for one hour in a desiccator to remove solvent 
traces. 
The next mixtures of lipids were used: 
Egg phosphatidylcholine: cholesterol 1:1 (EPC:Chol 1:1)  
Egg phosphatidylcholine: cholesterol 2:1 (EPC:Chol 2:1) 
Egg phosphatidylcholine: stearoylamine: cholesterol 5:1:4 (EPC: SA: Chol 5:1:4) 
Egg phosphatidylcholine: stearoylamine: cholesterol 2:1:1 (EPC: SA: Chol 2:1:1) 
Egg phosphatidylcholine: cholylsarcosine: cholesterol 5:1:4 (EPC:CS:Chol 5:1:4) 
Egg phosphatidylcholine: cholylsarcosin: cholesterol 2:1:1 (EPC:CS:Chol 2:1:1)  
Egg phosphatidylcholine: vitamin E: cholesterol 5:1:4 (EPC: TPGS: Chol 5:1:4) 
Egg phosphatidylcholine: vitamin E: cholesterol 10:1:9 (EPC: TPGS: Chol 10:1:9) 
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Tab. 5 Mixtures of lipids in various proportions.  
mixtures of lipids 
Aqueous media (1ml) FD 
Treh Suc PBS 
Suc /NaCl + 
PVP 
48 
EPC:Chol 1:1 •       • 
  •     • 
    •   • 
      • • 
EPC:Chol 2:1 •       • 
  •     • 
    •   • 
      • • 
EPC:SA:Chol 5:1:4 •       • 
  •     • 
EPC:SA:Chol 2:1:1 •       • 
  •     • 
EPC:CS:Chol 5:1:4 •       • 
  •     • 
EPC:CS:Chol 2:1:1 •       • 
    •     • 
EPC:TPGS:Chol 5:1:4 •       • 
  •     • 
EPC:TPGS:Chol 
10:1:9 
•       • 
  •     • 
4.3.2 Hydration 
I took the vial from desiccator and I added the magnetic stirrer and glass beads to the 
dry sample. Then I added 1 ml of aqueous medium: 6.8% trehalose with 0.3% NaCl, 
10% succrose, PBS, and 2% sucrose with 0.7% NaCl, respectively. In order to 
dissolve the film of lipids, the sample was stirred for 30 minutes in the glass vial. I 
left the samples of 30 minutes at room temperature at rest. 
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4.3.3 Extrusion 
I took the sample after hydration. Between the cylinders of the Liposofast extruder I 
have put a membrane with a pore size of 200 nm. I rinsed the extruder one time with 
aqueous medium and extruded the sample in an unpaired number, i.e. odd number of 
pushing through the membrane, to reduce contamination of the sample, in my case 
41 times. I injected the sample from the syringe into a clean Eppendorf cup and 
stored at 4° C in the fridge. I prepared all samples three times. 
4.4 Freeze drying (FD) 
I weight a lyo-vial with a stopper on an analytical balance. Into the vials I injected a 
dispersion of the extruded LUV and weight the vial with the sample again. In case of 
suspension (Suc/NaCl), I added to samples 20% Plasdone K – 29/32 Povidon (PVP) 
in quantities of 20% of the original sample. I put vial in the freeze – dryer. After 
placing the sample in the drying chamber I closed the lid and the process was started. 
I engaged freeze drying of liposome under following conditions: 
freezing -30° C, 8 hours   
primary drying –10° C, 32 hours, 37 Pa,   
secondary drying 10° C, 8 hours 
The Delta 1-20 KD freeze-dryer announced the end of the process with a beeping 
signal. To avoid air contact of the sample I flooded the drying chamber with argon. I 
closed the lyo-vial directly in the chamber under the argon atmosphere. I left the lyo-
vials at room temperature and for 20 minutes to let them equilibrate.  
I noted the visual properties of the product and I reconstituted the dry cake with 
distilled water. The quantity of distilled water is equal to the quantity of the sample 
prior to freeze drying. I observed the solubility of the product carefully.  
In the last step I measured PCS for control of quality product. 
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4.5 Control of liposomes quality 
The measurement of liposome size and polydisperzity due to PCS. 
I used a Zetasizer for measururing the size of the liposomes and their polydisperzity 
that way that I diluted the sample in relevant aqueous media in the range 1:200 – 
1:600 after extrusion. I used the original aqueous media of the sample. I added 2 ml 
of aqueous media and 10 µl of the sample and 2 ml of aqueous media and 5 µl of the 
sample, etc, into a 4.5 ml plastic cuvette. I added the aqueous media by the syringe 
with a sterile filter with pore size 0.22 µm. I placed the plastic cuvette into cell on the 
backside of the measuring chamber. Properly, I closed a lid. 
In the first step I checked the concentration of the sample. The kilo counts per second 
(kCps - the photons per second on the multiplier divided by thousand) should be 
between 100 – 200 kCps (50 – 250 is still tolerable). The measurements were done at 
the temperature of 30° C, intensity of the scattered light of 90°, and wavelength of 
633 nm. Refractive index by trehalose with NaCl was 1,3423 and 10% sucrose 
1,3462. In a routine measurement, the Zetasizer measure 3 times 10 single runs (10 – 
30 min). 
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5 Results and discussion 
All mixtures of liposomes I prepared for each experiment 3 times. For each sample I 
conduct a quality of control by measuring of PCS and observed visual characteristics. 
In tables and graphs, the average values are presented. 
Each sample was measured by PCS to verify size and polydispersity (PI) of the 
liposomes before and after the freeze drying. The polydispersity is a parameter which 
indicates the width of the distribution. For strongly monodisperse populations, it is 
under 0.1 a polydispersity under 0.2 still indicates a monodisperse distribution.  
During a single measuring each sample was measured 30 times. These 30 measuring 
were divided into three tens. For each of the three tens, the software calculated 
values of size and PI and then calculated the final value of size and PI. In tables, the 
values of PI and size are presented with arithmetical mean value () and standard 
deviation (in brackets). 
After freeze-drying, the visual characteristics of the product (the appearance) and 
solubility in the water was observed. The appearance was evaluated according to the 
color and shape of each sample after freeze drying. The sample should be in the 
shape of a cake. The solubility was observed by adding an appropriate amount of 
distilled water. The sample after freeze drying should be fast and well-soluble. 
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5.1 The selecting of appropriate media 
Two lipids dispersions EPC:Chol 1:1 and EPC:Chol 2:1 in various aqueous media: 
6.8% trehalose with 0.3% NaCl, 10% succrose, PBS and 2% sucrose/ 0.7% NaCl wit 
PVP were prepared. All samples were extruded through the membrane with pore size 
200 nm. The results of experimental measurements are summarized in Tab. 6 -16. 
 It was evaluated: appearance–white (w), transparent (t), cake, network or net cake; 
solubility in distilled water–fast and good solubility (+) and slow solubility (-); size 
and polydispersity was determined by PCS.  
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Tab. 6 The measured values of liposome size and polydispersity in 6.8% 
trehalose/0.3%NaCl before freeze-drying. 
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 276.90 
289.53 
(10.98) 
0.11 
0.09 
(0.02) 
294.90 0.08 
296.80 0.07 
EPC:Chol 2:1 285.20 
277.90 
(6.68) 
0.07 
0.10 
(0.05) 
276.40 0.08 
272.10 0.15 
 
Tab.7 The measured values of liposome size and polydispersity in 
6.8%trehalose/0.3%NaCl after freeze drying.  
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI  Ø PI  
EPC:Chol 1:1 290.20 
322.93 
(28.64) 
0.11 
0.12 
(0.03) 
343.40 0.14 
335.20 0,09 
EPC:Chol 2:1 299.40 
295.97 
(3.73) 
0.13 
0.13 
(0.02) 
292.00 0.14 
296.50 0.11 
 
Tab.8 The properties of freeze-dryied samples in 6.8%trehalose/ 0.3%NaCl.  
Mixtures of 
lipids 
Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w cake + 0.90 0.06 
w cake + 0.83 0.06 
w cake + 0.65 0.05 
EPC:Chol 2:1 w cake + 0.89 0.06 
w cake + 0.79 0.06 
w cake + 0.62 0.05 
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Tab.9 The measured values of liposome size and polydispersity in 2% sucrose/0.7% 
NaCl with PVP before freeze-drying. 
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 269.70 
265.73 
(21.13) 
0.06 
0.09 
(0.03) 
284.60 0.08 
242.90 0.11 
EPC:Chol 2:1 310.00 
284.63 
(22.87) 
0.14 
0.13 
(0.01) 
265.60 0.12 
278.30 0.13 
 
The samples after freeze drying were impossible to measuring due to PCS. 
 
Tab.10 The properties of freeze-dryied samples in 2%sucrose/ 0.7%NaCl with PVP.  
Mixtures of 
lipids 
Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w network ‐ 0.92 0.07 
w network ‐ 0.86 0.06 
w network ‐ 0.89 0.26 
EPC:Chol 2:1 w network ‐ 0.89 0.06 
w network ‐ 0.96 0.07 
w network ‐ 0.99 0.07 
 
Tab.11 The measured values of liposome size and polydispersity in 10% sucrose 
before freeze-drying. 
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 301.50 
307.50 
(22.02) 
0.15 
0.15 
(0.04) 
289.10 0.18 
331.90 0.10 
EPC:Chol 2:1 274.40 
282.83 
(7.32) 
0.06 
0.09 
(0.02) 
286.60 0.10 
287.50 0.09 
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Tab.12 The measured values of liposome size and polydispersity in 10% sucrose 
after freeze-drying. 
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 237.10 
232.10 
(7.00) 
0.07 
0.09 
(0.04) 
224.10 0.07 
235.10 0.14 
EPC:Chol 2:1 214.70 
226.47 
(10.21) 
0.13 
0.14 
(0.00) 
231.70 0.14 
233.00 0.14 
 
Tab.13 The properties of freeze-dryied samples in 10% sucrose. 
Mixtures of 
lipids 
Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w cake + 0.84 0.09 
w cake + 0.93 0.10 
w cake + 0.93 0.10 
EPC:Chol 2:1 w cake + 0.81 0.08 
w cake + 0.65 0.07 
w cake + 0.73 0.08 
 
Tab.14 The values of liposome size and polydispersity in phosphate buffer saline 
before freeze-drying. 
Mixtures of 
lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 266.80 
266.73 
(0.40) 
0.06 
0.05 
(0.01) 
267.10 0.04 
266.30 0.04 
EPC:Chol 2:1 255.30 
261.70 
(5.74) 
0.03 
0.09 
(0.05) 
263.40 0.13 
266.40 0.10 
The samples were impossible to measured due to PCS after freeze drying 
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Tab. 15 The properties of freeze-dryied samples in phosphate buffer saline. 
Mixtures of 
lipids 
Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w network ‐ 0.74 0.01 
w network ‐ 0.78 0.02 
w network ‐ 0.77 0.02 
EPC:Chol 2:1 w network ‐ 0.75 0.02 
w network ‐ 0.70 0.01 
w network ‐ 0.74 0.01 
 
Tab.16 The overview of average of liposome size and polydispersity and properties 
of the samples. 
Mixtures of 
lipids 
Aqueous media 
Ø Size 
[nm] Ø PI 
Ø Size 
[nm] 
FD 
Ø PI 
FD 
Appearance 
Solubility 
in H2O 
EPC:Chol 1:1 Treh/NaCl 289.50 0.09 322.90 0.12 w cake + 
Suc/NaCl with 
PVP 265.70 0.09 0.00 0.00 w network ‐ 
10% Suc 307.50 0.09 232.10 0.09 w cake + 
PBS 266.70 0.09 0.00 0.00 w network ‐ 
EPC:Chol 2:1 Treh/NaCl 277.90 0.10 295.90 0.13 w cake + 
Suc/NaCl with 
PVP 284.60 0.13 0.00 0.00 w network ‐ 
10% Suc 282.80 0.09 226.40 0.14 w cake + 
PBS 261.70 0.09 0.00 0.00 w network ‐ 
Liposomes composed of (EPC: Chol 1:1) were much larger in size than the pore 
diameter membrane. This is due to the high proportion of cholesterol. Liposomes 
composed of (EPC: Chol 2:1) were smaller. From this (Tab.16) it is clear, that the 
appropriate aqueous media for freeze drying were trehalose/NaCl and sucrose. 
Sucrose is a very common medium and trehalose leads to a molar ratio of sugar to 
lipid from 20:1 for a liposomal dispersion of 10 µmol/ml lipid. NaCl was added to 
achieve an isotonicity.  
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In these mediums are products of freeze drying fast and good soluble and have the 
shape of cake with white color. In PBS and 2% sucrose/NaCl with PVP was prepared 
samples impossible to measuring. Usually PVP is used to reduce fusion of the 
liposomes during the drying.
34
 The PVP formed aggregates with the liposomes and 
so the samples are impossible to measured. In the case of PBS no lyo- and 
cryoprotectant has been used so the samples could not be protected. 
There are several reasons why the liposome size can change after reconstitution. An 
increase in size can be caused by the fusion of liposomes. This also leads to an 
increase of the polydispersity. Liposomes can undergo phase transition during the 
reconstitution with water. They are often in the glassy state when they are dried and 
will be again in the fluid crystalline state after reconstitution. During this phase 
transition the liposomes are very unstable and leakage but also fusion and 
fragmentation can occur. The ice crystals during the freezing can damage the 
liposomal membranes and thus induce fragmentation and later reorganisation of the 
liposomes. This can reduce the size and the polydispersity. Finally the liposomes 
might be not totally rehydrated directly after the reconstitution with water and are 
therefore smaller. 
In comparison, trehalose and sucrose seem to be preferable lyoprotectants for 
biomolecules. The roles of sugars, trehalose and sucrose, include the stabilization of 
membrane by lowering the lipid phase transition temperature and the prevention of 
liposome aggregation and fusion.
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 Because they stabilise the liposomes during the 
freezing and drying, they have a stabilising influence on the liposome size and the 
polydispersity. Other properties of trehalose are also considered to be advantageous, 
which include, less hygroscopicity, an absence of internal hydrogen bonds, which 
allows more flexible formation of hydrogen bonds with proteins, and very low 
reactivity.
36
  
The sucrose could be equally effective in protecting biomolecules. In reality, the 
relative stabilization effect of these two sugars seems to be depended on both the 
protein and sugar concentration. Based on the results of the liposome size and 
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polydispesity was chosen sucrose and trehalose to study properties of liposomes 
consisted of three lipids. 
5.2 Freeze drying of liposomes  
The mixtures of three lipids were prepared in different proportions in two aqueous 
media: 6.8% trehalose/0.3% NaCl and 10% sucrose. All samples were extruded 
through the membrane with pore size 200nm. The results of experimental 
measurements are summarized in Tab. 17-23. 
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Tab.17 The measured values of liposome size and polydispersity in 6.8% 
trehalose/0.3%NaCl before freeze drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:SA:Chol 5:1:4 275.30 
279.70 
(7.19) 
0.09 
0.09 
(0.01) 
275.80 0.08 
288.00 0.07 
EPC:SA:Chol 2:1:1 267.20 
277.60 
(1.53) 
0.12 
0.15 
(0.03) 
290.00 0.17 
275.60 0.1 
EPC:CS:Chol 5:1:4 240.90 
230.63 
(1.54) 
0.08 
0.11 
(0.03) 
242.90 0.14 
208.10 0.10 
EPC:CS:Chol 2:1:1 188.60 
192.47 
(3.42) 
0.07 
0.10 
(0.04) 
195.10 0.08 
193.70 0.14 
EPC:TPGS:Chol 5:1:4 187.90 
183.37 
(1.77) 
0.10 
0.10 
(0.02) 
192.20 0.11 
170.00 0.07 
EPC:TPGS:Chol 
10:1:9 
203.20 
200.90 
(7.62) 
0.10 
0.12 
(0.02) 
192.40 0.14 
207.10 0.11 
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Tab. 18 The measured values of liposome size and polydispersity in 6.8% 
trehalose/0.3%NaCl after freeze drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:SA:Chol 5:1:4 262.10 
264.27 
(8.75) 
0.12 
0.15 
(0.02) 
256.80 0.16 
273.90 0.15 
EPC:SA:Chol 2:1:1 273.20 
278.13 
(8.81) 
0.11 
0.11 
(0.01) 
288.30 0.12 
272.90 0.10 
EPC:CS:Chol 5:1:4 182.50 
209.63 
(4.88) 
0.09 
0.14 
(0.04) 
267.20 0.18 
179.20 0.13 
EPC:CS:Chol 2:1:1 165.70 
167.30 
(1.44) 
0.21 
0.17 
(0.05) 
167.70 0.18 
168.50 0.11 
EPC:TPGS:Chol 5:1:4 200.60 
207.13 
(5.66) 
0.13 
0.18 
(0.04) 
210.40 0.21 
210.40 0.18 
EPC:TPGS:Chol 
10:1:9 
195.20 
199.17 
(4.59) 
0.10 
0.15 
(0.04) 
204.20 0.16 
198.10 0.18 
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Tab.19 The properties of freeze-dryied samples in 6.8%trehalose/ 0.3%NaCl. 
Mixtures of lipids Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:SA:Chol 5:1:4 w net-cake + 0.86 0.06 
w cake + 0.83 0.06 
w cake + 0.83 0.06 
EPC:SA:Chol 2:1:1 w cake + 0.81 0.06 
w cake + 0.83 0.06 
w cake + 0.77 0.05 
EPC:CS:Chol 5:1:4 w net-cake + 0.79 0.06 
w net-cake ‐ 0.88 0.07 
w cake + 0.67 0.05 
EPC:CS:Chol 2:1:1 w net-cake ‐ 0.77 0.06 
w cake ‐ 0.73 0.05 
w cake ‐ 0.83 0.06 
EPC:TPGS:Chol 5:1:4 w net-cake + 0.79 0.06 
w net-cake + 0.54 0.04 
w net-cake + 0.65 0.05 
EPC:TPGS:Chol 
10:1:9 
w cake + 0.62 0.05 
w net-cake + 0.68 0.05 
w cake + 0.58 0.04 
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Tab. 20 The measured values of liposome size and polydispersity in 10% sucrose 
before freeze-drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:SA:Chol 5:1:4 251.80 
251.53 
(4.81) 
0.09 
0.11 
(0.05) 
246.60 0.16 
256.20 0.06 
EPC:SA:Chol 2:1:1 340.30 
350.00 
(9.51) 
0.22 
0.24 
(0.07) 
350.40 0.17 
359.30 0.32 
EPC:CS:Chol 5:1:4 201.30 
212.73 
(12.57) 
0.20 
0.13 
(0.07) 
210.70 0.07 
226.20 0.10 
EPC:CS:Chol 2:1:1 214.20 
211.83 
(2.30) 
0.11 
0.11 
(0.01) 
211.70 0.09 
209.60 0.11 
EPC:TPGS:Chol 5:1:4 204.50 
199.27 
(4.79) 
0.13 
0.12 
(0.02) 
198.20 0.13 
195.10 0.09 
EPC:TPGS:Chol 
10:1:9 
209.10 
210.07 
(18.37) 
0.10 
0.09 
(0.02) 
228.90 0.07 
192.20 0.09 
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Tab. 21 The measured values of liposome size and polydispersity in 10% sucrose 
after freeze-drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:SA:Chol 5:1:4 212.50 
254.53 
(40.81) 
0.12 
0.14 
(0.02) 
294.00 0.14 
257.10 0.15 
EPC:SA:Chol 2:1:1 275.90 
281.43 
(24.77) 
0.15 
0.17 
(0.02) 
308.50 0.19 
259.90 0.16 
EPC:CS:Chol 5:1:4 175.60 
187.47 
(10.28) 
0.09 
0.10 
(0.02) 
193.10 0.09 
193.70 0.12 
EPC:CS:Chol 2:1:1 190.70 
195.00 
(7.19) 
0.07 
0.10 
(0.06) 
203.30 0.06 
191.00 0.17 
EPC:TPGS:Chol 5:1:4 184.60 
187.13 
(4.56) 
0.08 
0.13 
(0.04) 
184.40 0.13 
192.40 0.17 
EPC:TPGS:Chol 
10:1:9 
187.40 
195.80 
(7.57) 
0.17 
0.11 
0.06) 
202.10 0.08 
197.90 0.06 
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Tab. 22 The properties of freeze-dryied samples in 10% sucrose. 
Mixtures of lipids Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:SA:Chol 5:1:4 w cake + 0.62 0.05 
w cake + 0.68 0.05 
w cake + 0.58 0.04 
EPC:SA:Chol 2:1:1 w cake + 0.53 0.06 
w cake + 0.87 0.10 
w cake + 0.78 0.09 
EPC:CS:Chol 5:1:4 w cake + 0.83 0.09 
w cake + 0.77 0.08 
w cake + 0.72 0.07 
EPC:CS:Chol 2:1:1 w net-cake + 0.89 0.09 
w cake + 0.92 0.09 
w cake + 0.77 0.08 
EPC:TPGS:Chol 5:1:4 w cake + 0.79 0.09 
w cake + 0.81 0.08 
w cake + 0.83 0.09 
EPC:TPGS:Chol 
10:1:9 
w cake + 0.61 0.06 
w cake + 0.64 0.07 
w cake + 0.71 0.07 
 
50 
 
Tab. 23 Overview of average values in trehalose and sucrose 
Mixtures of lipids 
Aqueous 
media 
 
Ø Size 
[nm] 
Ø PI 
Ø Size 
[nm] 
FD 
Ø PI 
FD 
Appearance 
Solubility 
in H2O 
EPC:SA:Chol 5:1:4 Treh/NaCl 279.70 0.09 264.27 0.15 w cake + 
10 % Suc 251.54 0.11 254.54 0.14 w cake + 
EPC:SA:Chol 2:1:1 Treh/NaCl 277.60 0.15 278.14 0.11 w cake + 
10 % Suc 350.00 0.24 281.43 0.17 w cake + 
EPC:CS:Chol 5:1:4 Treh/NaCl 230.63 0.11 209.63 0.14 w net-cake + 
10 % Suc 212.74 0.13 187.14 0.10 w cake + 
EPC:CS:Chol 2:1:1 Treh/NaCl 192.47 0.10 167.30 0.17 w cake ‐ 
10 % Suc 211.84 0.11 195.00 0.10 w cake + 
EPC:TPGS:Chol 5:1:4 Treh/NaCl 183.37 0.10 207.13 0.18 w net-cake + 
10 % Suc 199.27 0.12 187.14 0.13 w cake + 
EPC:TPGS:Chol 
10:1:9 
Treh/NaCl 200.90 0.12 199.17 0.15 w cake + 
10 % Suc 210.07 0.09 195.80 0.11 w cake + 
Liposomes composed of three lipids are fairly stable, the samples were fast and good 
soluble, except of the sample (EPC:CS:Chol 2:1:1) which was dissolved slowly. 
Stability during freeze-drying is influenced by the composition of lipids. Due to the 
high cholesterol content, liposomal membrane was more fluid and liposomes were 
larger than the pores of the membrane.
37
 It was used EPC:Chol as a basic formulation 
for liposomes, but this formulation was rather unstable, so it was stabilized with 
vitamin E (TPGS).  
Liposomes composed of EPC:TPGS:Chol, were prepared with size almost equivalent 
to the pores of the membrane. This confirmed the assumption that incorporation of 
TGPS to the membrane of the liposomes affects their size, making them usually 
smaller. To improve the property of the liposomes to act as an absorption enhancer, it 
was added components like stearoylamine (SA). Cationic lipids are good 
bioenhancer and SA is furthermore pretty cheap. Cholylsarcosine (CS) acts also as a 
bioenhancer. SA prevents aggregation of liposomes due to its positive charge. The 
rather high intermolecular interaction of the stearylgroups can increase the 
membrane rigidity and therefore reduce the size of the liposomes. One of the factors 
in determining the extent to which sugars such as trehalose and sucrose can protect 
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liposomes during dehydratation, is a vesicle size. The size has an impact on the 
conservation of the content liposomes.
35
  
Based on the results of the liposome size, the polydispesity and cholesterol content 
was chosen the samples EPC:SA:Chol 5:1:4, EPC:CS:Chol 5:1:4 and 
EPC:TPGS:Chol 5:1:4. 
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5.3 Study of liposome stability 
The mixtures of three lipids were prepared in two aqueous media: 6.8% 
trehalose/0.3% NaCl and 10% sucrose. All samples were extruded through the 
membrane with pore size 200nm. After freeze-drying samples were left of 3 weeks at 
room temperature at rest in the laboratory. The results of experimental measurements 
are summarized in Tab 24 - 30. Influence of the freeze-drying on the liposome size 
and polydispersity index are illustrated in Fig. 13 -Fig. 16. 
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Tab.24 The measured values of liposome size and polydispersity in 6.8% 
trehalose/0.3%NaCl before freeze drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 213.70 
225.30 
(11.86) 
0.08 
0.11 
(0.07) 
237.40 0.18 
224.80 0.06 
EPC:SA:Chol 5:1:4 180.50 
192.80 
(10.66) 
0.06 
0.06 
(0.02) 
199.20 0.09 
198.70 0.05 
EPC:CS:Chol 5:1:4 176.90 
184.07 
(19.37) 
0.05 
0.09 
(0.04) 
169.30 0.14 
206.00 0.09 
EPC:TPGS:Chol 
5:1:4 
178.60 
175.63 
(2.61) 
0.06 
0.09 
(0.03) 
174.60 0.09 
173.70 0.13 
 
Tab.25 The measured values of liposome size and polydispersity in 6.8%trehalose/ 
0.3%NaCl after freeze-drying, after 3 weeks storage at room temperature. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 236.60 
251.83 
(22.93) 
0.16 
0.20 
(0.10) 
278.20 0.31 
240.70 0.13 
EPC:SA:Chol 5:1:4 206.70 
209.40 
(5.29) 
0.24 
0.20 
(0.03) 
206.00 0.18 
215.50 0.19 
EPC:CS:Chol 5:1:4 140.00 
150.67 
(9.52) 
0.13 
0.14 
(0.06) 
153.70 0.22 
158.30 0.09 
EPC:TPGS:Chol 
5:1:4 
260.90 
288.93 
(70.00) 
0.38 
0.47 
(0.21) 
237.30 0.32 
368.60 0.72 
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Tab.26 The properties of freeze-dryied samples in 6.8%trehalose/ 0.3%NaCl after 3 
weeks storage at room temperature. 
Mixtures of lipids Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w cake ± 0.59 0.04 
t network ‐ 0.66 0.05 
t network ‐ 0.90 0.07 
EPC:SA:Chol 5:1:4 w cake + 0.81 0.05 
w cake + 0.91 0.06 
w cake + 0.87 0.06 
EPC:CS:Chol 5:1:4 w cake + 0.61 0.04 
w cake + 0.74 0.05 
w cake + 0.85 006 
EPC:TPGS:Chol 
5:1:4 
w net-cake + 0.86 0.06 
w net-cake + 0.86 0.06 
w net-cake + 0.78 0.05 
 
Tab.27 The measured values of liposome size and polydispersity in 10% sucrose 
before freeze-drying. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 218.30 
221.57 
(2.84) 
0.18 
0.15 
(0.03) 
223.40 0.16 
223.00 0.12 
EPC:SA:Chol 5:1:4 199.60 
201.80 
(7.06) 
0.13 
0.12 
(0.02) 
209.70 0.10 
196.10 0.14 
EPC:CS:Chol 5:1:4 201.40 
194.40 
(13.71) 
0.13 
0.15 
(0.10) 
203.20 0.27 
178.60 0.06 
EPC:TPGS:Chol 
5:1:4 
181.60 
197.77 
(14.52) 
0.25 
0.19 
(0.06) 
202.00 0.17 
209.70 0.14 
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Tab.28 The values of liposome size and polydispersity in 10% sucrose after freeze-
drying, after 3 weeks storage at room temperature. 
Mixtures of lipids 
Size 
[nm] 
Ø Size 
[nm] PI Ø PI 
EPC:Chol 1:1 215.30 
217.07 
(5.47) 
0.18 
0.13 
(0.04) 
223.20 0.11 
212.70 0.11 
EPC:SA:Chol 5:1:4 271.20 
253.10 
(17.11) 
0.37 
0.40 
(0.04) 
250.90 0.44 
237.20 0.38 
EPC:CS:Chol 5:1:4 179.10 
174.57 
(5.00) 
0.08 
0.10 
(0.03) 
175.40 0.09 
169.20 0.14 
EPC:TPGS:Chol 
5:1:4 
201.80 
206.53 
(4.70) 
0.11 
0.12 
(0.02) 
206.60 0.14 
211.20 0.10 
 
Tab.29 The properties of freeze-dryied samples in 10% sucrose after 3 weeks storage 
at room temperature. 
Mixtures of lipids Appearance 
Solubility 
in H2O 
Weight 
of 
sample 
[g] 
Weight 
of 
sample 
FD [g] 
EPC:Chol 1:1 w network ‐ 0.58 0.06 
w cake + 0.88 0.09 
w cake + 0.67 0.07 
EPC:SA:Chol 5:1:4 t network ‐ 0.91 0.10 
t network ‐ 0.83 0.09 
t network ‐ 0.84 0.09 
EPC:CS:Chol 5:1:4 w cake + 0.64 0.07 
w cake + 0.82 0.08 
t network ‐ 0.77 0.08 
EPC:TPGS:Chol 
5:1:4 
w cake + 0.79 0.08 
w cake + 0.87 0.09 
w cake + 0.75 0.07 
 
56 
 
Tab. 30 Overview of average values in trehalose and sucrose 
Mixtures of lipids 
Aqueous 
media 
Ø Size 
[nm] Ø PI 
Ø Size 
[nm] 
FD 
Ø PI 
FD 
Appearance 
Solubility 
in H2O 
EPC:Chol 1:1 Treh/NaCl 225.30 0.11 251.83 0.20 t net-cake ‐ 
10 % Suc 221.57 0.15 217.07 0.13 w cake + 
EPC:SA:Chol 
5:1:4 
Treh/NaCl 192.80 0.06 209.40 0.20 w cake + 
10 % Suc 201.80 0.12 286.43 0.40 t network ‐ 
EPC:CS:Chol 
5:1:4 
Treh/NaCl 184.07 0.09 150.67 0.14 w cake + 
10 % Suc 194.40 0.15 174.57 0.10 w cake + 
EPC:TPGS:Chol 
5:1:4 
Treh/NaCl 175.63 0.09 288.93 0.47 w net-cake + 
10 % Suc 197.77 0.19 206.53 0.12 w cake + 
In this Tab. 30, the values of samples after freeze-drying are recorded, measured 
after three weeks storage. Even in appearance, it is clear that the samples: EPC:Chol 
1:1 in Suc, EPC:SA:Chol 5:1:4 in Treh/NaCl, EPC:CS:Chol 5:1:4 in Treh/NaCl and 
Suc, EPC:TPGS:Chol 5:1:4 in Suc are stable.  
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Fig. 13 The influence of the freeze-drying in trehalose on liposome size. The change 
of liposome size before, after freeze – drying and after three weeks storage at room 
temperature. 
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Fig. 14 The influence of the freeze-drying in trehalose on polydispersity index. The 
change of polydispersity before, after freeze-drying and after 3 weeks storage at 
room temperature.  
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Study of liposome stability showed, that the influence of freeze - drying increased 
the liposome size and polydispersity in the mixture consisted of EPC:TPGS:Chol 
5:1:4. The increase in size can be caused by the fusion of liposomes. This also leads 
to an increase of the polydispersity. The freeze-dryied samples had the shape of 
white net cake. The appearance and increase of the liposome size after three weeks 
storage showed, that this mixture is unstable. 
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Fig. 15 The influence of the freeze-drying in sucrose on liposome size. The change 
of liposome size before, after freeze-drying and after three weeks storage at room 
temperature. 
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Fig. 16 The influence of the freeze-drying in sucrose on polydispersity index. The 
change of polydispersity before, after freeze-drying and after 3 weeks storage at 
room temperature. 
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In the case of sucrose, stability studies shows, that the storage and freeze – drying did 
not have a large influence of liposome size and polydispersity, except of the mixture 
consisted of EPC:SA:Chol 5:1:4. The variability of liposome size could be caused by 
manual extrusion. The freeze-dryied samples had the shape of white net cake. The 
appearance and increase of the liposome size after three weeks storage showed, that 
this mixture is unstable.  
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6 Conclusion 
During the experimental stage of this work, it was achieved by manual extrusion to 
prepare liposomes of different sizes, which has been shown that the liposome size 
depends on their composition. The higher cholesterol content increases the fluidity of 
liposomal membrane, causing the formation of liposomes larger than the membrane 
pores of extruder. By the liposomes containing stearoylamine and cholylsarcosine 
were measured size as the membrane pores of extruder. Liposomes containing 
vitamin E were of smaller size due to the polyethylenglycol chains; these chains 
increased stability through the prevention of aggregation. 
The freeze-drying is crucial for the preparation of stable drugs forms, because freshly 
prepared liposomes succumb to degradation. It has been shown, that the appropriate 
media for freeze-drying are trehalose and sucrose. Both these lyo- and 
cryoprotectants were evaluated as the most, on the basic of appearance, solubility in 
the water and values of size and polydispersity. Liposomes consisted of three lipids 
extended the stability after three weeks storage at room temperature. These 
liposomes did not change the shape of white cake, fast and good solubility in the 
water. The liposome size did not show major changes and the polydispersity was low 
except of mixture EPC:TPGS:Chol 5:1:4 in trehalose, the increase in size and 
polydispersity can be caused by the fusion of liposomes, and EPC:SA:Chol 5:1:4. 
The variability of liposome size could be caused by manual extrusion. 
In studying the stability of liposomes we made only the first step. In the another step 
will be to verify the water content by method Karl Fisher, determination of the 
amount of the incorporated drug, they are able to hold inside, and many other studies. 
The whole research should lead towards administration of peptide drugs (e.g. insulin 
or calcitonin) by oral application. 
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7 Summary 
The protein or peptide substances are not appropriate for oral application. One of the 
many obstacles, is an aggressive environment of the gastrointestinal tract. One way 
to protect these substances is the preparation of liposomes. The aim of this work was 
preparation of liposomes of the different composition, choice of the optimum 
aqueous media, and stabilization using freeze-drying. All samples consisted of egg 
phosphatidylcholine(EPC) and cholesterol (Chol), with the addition of one out of the 
substances: cholylsarcosine (CS), stearoylamine (SA) and vitamin E (TPGS), 
respectively, in various ratio. Liposomes were prepared using a film method and 
manual extrusion through membrane with pore size 200 nm. The liposome size and 
polydispersity was measured by photon corellation spectroscopy. After the extrusion, 
the liposomes underwent freeze-drying in the presence of selected appropriate 
cryoprotectants: sucrose and trehalose, respectively. Stability has been established by 
evaluating the visual characteristics of the product (the appearance), solubility in the 
water and measuring of liposome size and polydispersity. 
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